<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Ettou S</submitter><funding>NIBIB NIH HHS</funding><funding>NCATS NIH HHS</funding><funding>NIDDK NIH HHS</funding><funding>National Institute of Diabetes and Digestive and Kidney Diseases</funding><funding>Uehara Memorial Foundation</funding><pagination>eabb5460</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7380960</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6(30)</volume><pubmed_abstract>In the context of human disease, the mechanisms whereby transcription factors reprogram gene expression in reparative responses to injury are not well understood. We have studied the mechanisms of transcriptional reprogramming in disease using murine kidney podocytes as a model for tissue injury. Podocytes are a crucial component of glomeruli, the filtration units of each nephron. Podocyte injury is the initial event in many processes that lead to end-stage kidney disease. Wilms tumor-1 (WT1) is a master regulator of gene expression in podocytes, binding nearly all genes known to be crucial for maintenance of the glomerular filtration barrier. Using murine models and human kidney organoids, we investigated WT1-mediated transcriptional reprogramming during the course of podocyte injury. Reprogramming the transcriptome involved highly dynamic changes in the binding of WT1 to target genes during a reparative injury response, affecting chromatin state and expression levels of target genes.</pubmed_abstract><journal>Science advances</journal><pubmed_title>Epigenetic transcriptional reprogramming by WT1 mediates a repair response during podocyte injury.</pubmed_title><pmcid>PMC7380960</pmcid><funding_grant_id>U01 EB028899</funding_grant_id><funding_grant_id>DP2 DK133821</funding_grant_id><funding_grant_id>UG3 TR002155</funding_grant_id><funding_grant_id>1R01DK109972</funding_grant_id><funding_grant_id>R01 DK091299</funding_grant_id><funding_grant_id>DK091299</funding_grant_id><funding_grant_id>U01 DK127587</funding_grant_id><funding_grant_id>R01 DK109972</funding_grant_id><funding_grant_id>UH3 TR002155</funding_grant_id><funding_grant_id>DP2EB029388</funding_grant_id><pubmed_authors>Park PJ</pubmed_authors><pubmed_authors>Schumacher V</pubmed_authors><pubmed_authors>Kreidberg JA</pubmed_authors><pubmed_authors>Miyoshi T</pubmed_authors><pubmed_authors>Taglienti ME</pubmed_authors><pubmed_authors>Hiratsuka K</pubmed_authors><pubmed_authors>Ettou S</pubmed_authors><pubmed_authors>Morizane R</pubmed_authors><pubmed_authors>Jung YL</pubmed_authors><pubmed_authors>Jain D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Epigenetic transcriptional reprogramming by WT1 mediates a repair response during podocyte injury.</name><description>In the context of human disease, the mechanisms whereby transcription factors reprogram gene expression in reparative responses to injury are not well understood. We have studied the mechanisms of transcriptional reprogramming in disease using murine kidney podocytes as a model for tissue injury. Podocytes are a crucial component of glomeruli, the filtration units of each nephron. Podocyte injury is the initial event in many processes that lead to end-stage kidney disease. Wilms tumor-1 (WT1) is a master regulator of gene expression in podocytes, binding nearly all genes known to be crucial for maintenance of the glomerular filtration barrier. Using murine models and human kidney organoids, we investigated WT1-mediated transcriptional reprogramming during the course of podocyte injury. Reprogramming the transcriptome involved highly dynamic changes in the binding of WT1 to target genes during a reparative injury response, affecting chromatin state and expression levels of target genes.</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jul</publication><modification>2025-04-05T15:19:16.114Z</modification><creation>2025-04-05T15:19:16.114Z</creation></dates><accession>S-EPMC7380960</accession><cross_references><pubmed>32754639</pubmed><doi>10.1126/sciadv.abb5460</doi></cross_references></HashMap>